BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31996468)

  • 1. The Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma Patients.
    Kumar S; Dhamija B; Marathe S; Ghosh S; Dwivedi A; Karulkar A; Sharma N; Sengar M; Sridhar E; Bonda A; Thorat J; Tembhare P; Shet T; Gujral S; Bagal B; Laskar S; Jain H; Purwar R
    Mol Cancer Res; 2020 Apr; 18(4):657-668. PubMed ID: 31996468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.
    Vieyra-Garcia PA; Wei T; Naym DG; Fredholm S; Fink-Puches R; Cerroni L; Odum N; O'Malley JT; Gniadecki R; Wolf P
    Clin Cancer Res; 2016 Jul; 22(13):3328-39. PubMed ID: 26851186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile.
    Querfeld C; Leung S; Myskowski PL; Curran SA; Goldman DA; Heller G; Wu X; Kil SH; Sharma S; Finn KJ; Horwitz S; Moskowitz A; Mehrara B; Rosen ST; Halpern AC; Young JW
    Cancer Immunol Res; 2018 Aug; 6(8):900-909. PubMed ID: 29895574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.
    Guenova E; Watanabe R; Teague JE; Desimone JA; Jiang Y; Dowlatshahi M; Schlapbach C; Schaekel K; Rook AH; Tawa M; Fisher DC; Kupper TS; Clark RA
    Clin Cancer Res; 2013 Jul; 19(14):3755-63. PubMed ID: 23785046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Interleukin-9 Producing Immune Cells in Endometrial Carcinoma and Establishment of a Prognostic Nomogram.
    Tong H; Feng H; Hu X; Wang MF; Song YF; Wen XL; Li YR; Wan XP
    Front Immunol; 2020; 11():544248. PubMed ID: 33329510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function.
    Wolk K; Mitsui H; Witte K; Gellrich S; Gulati N; Humme D; Witte E; Gonsior M; Beyer M; Kadin ME; Volk HD; Krueger JG; Sterry W; Sabat R
    Clin Cancer Res; 2014 Nov; 20(21):5507-16. PubMed ID: 25212608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma.
    Cao M; Lai P; Liu X; Liu F; Qin Y; Tu P; Wang Y
    Front Immunol; 2023; 14():1282996. PubMed ID: 38223508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors.
    Gaydosik AM; Tabib T; Geskin LJ; Bayan CA; Conway JF; Lafyatis R; Fuschiotti P
    Clin Cancer Res; 2019 Jul; 25(14):4443-4454. PubMed ID: 31010835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma.
    Kume M; Kiyohara E; Matsumura Y; Koguchi-Yoshioka H; Tanemura A; Hanaoka Y; Taminato M; Tashima H; Tomita K; Kubo T; Watanabe R; Fujimoto M
    Front Immunol; 2021; 12():651048. PubMed ID: 33859643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
    Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
    Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T
    Clark RA; Schlapbach C
    Semin Immunopathol; 2017 Jan; 39(1):47-54. PubMed ID: 27896634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression.
    Asadullah K; Haeussler-Quade A; Gellrich S; Hanneken S; Hansen-Hagge TE; Döcke WD; Volk HD; Sterry W
    Exp Dermatol; 2000 Aug; 9(4):248-51. PubMed ID: 10949545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib.
    Kießling MK; Nicolay JP; Schlör T; Klemke CD; Süss D; Krammer PH; Gülow K
    Oncotarget; 2017 Jul; 8(28):45687-45697. PubMed ID: 28537899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
    Wang Y; Gu X; Li W; Zhang Q; Zhang C
    J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Clinical, histopathologic, and immunohistochemical analyses.
    Nagatani T; Matsuzaki T; Iemoto G; Kim S; Baba N; Miyamoto H; Nakajima H
    Cancer; 1990 Dec; 66(11):2380-6. PubMed ID: 2245393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Targeting of MicroRNA-214 in Cutaneous T-Cell Lymphoma.
    Kohnken R; McNeil B; Wen J; McConnell K; Grinshpun L; Keiter A; Chen L; William B; Porcu P; Mishra A
    J Invest Dermatol; 2019 Sep; 139(9):1966-1974.e3. PubMed ID: 30876800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.
    Woetmann A; Lovato P; Eriksen KW; Krejsgaard T; Labuda T; Zhang Q; Mathiesen AM; Geisler C; Svejgaard A; Wasik MA; Ødum N
    Blood; 2007 Apr; 109(8):3325-32. PubMed ID: 17179233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
    Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
    Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.